Table 3.
Neurohormone levels in patients with and without diabetes in survivors and non-survivors.
| Diabetes | No diabetes | Diabetes vs. no diabetes | ||||||
|---|---|---|---|---|---|---|---|---|
| Survivors | Non-survivors | P value | Survivors | Non-survivors | P value | Survivors | Non-survivors | |
| Number of patients | 30 | 51 | 146 | 144 | P value | P value | ||
| Noradrenaline (pg/ml) | 412 (240-544) | 582 (436-737) | 0.002 | 444 (315-639) | 578 (415-754) | 0.000 | 0.21 | 0.90 |
| Adrenaline (pg/ml) | 36 (23-59) | 33 (19-70) | 0.88 | 35 (26-54) | 48 (30-79) | 0.002 | 0.64 | 0.035 |
| Dopamine (pg/ml) | 17 (12-28) | 23 (16-39) | 0.62 | 17 (11-30) | 22 (15-40) | 0.001 | 0.22 | 0.94 |
| Aldosterone (pg/ml) | 93 (49-222) | 93 (71-197) | 0.61 | 100 (55-189) | 139 (80-275) | 0.002 | 0.71 | 0.056 |
| Renin (μU/ml) | 83 (32-239) | 60 (23-229) | 0.32 | 64 (31-128) | 130 (53-327) | <0.001 | 0.34 | 0.002 |
| Endothelin (pg/ml) | 4.1 (3.5-12.1) | 5.1 (3.0-8.5) | 0.78 | 4.7 (3.1-10.8) | 6.2 (4.3-15.9) | 0.005 | 0.97 | 0.014 |
| ANP (pmol/l) | 90 (52-135) | 107 (83-218) | 0.019 | 79 (46-137) | 131 (89-204) | <0.001 | 0.72 | 0.75 |
| N-terminal (pro)ANP (pmol/l) | 812 (558-1165) | 1339 (932-2103) | 0.000 | 754 (462-1140) | 1340 (950-2287) | <0.001 | 0.86 | 0.68 |
| BNP (pmol/l) | 50 (17-102) | 119 (74-164) | 0.001 | 27 (11-72) | 81 (38-142) | <0.001 | 0.28 | 0.062 |
| N-terminal (pro)BNP (pmol/l) | 435 (234-827) | 811 (549-1991) | 0.001 | 327 (156-714) | 774 (509-1880) | <0.001 | 0.26 | 0.560 |
Data are median (IQR) unless otherwise indicated.